![[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients](https://i1.wp.com/ml-eu.globenewswire.com/media/NTJlMDkyZjktNGMwNi00N2YyLTkyZmQtZTIwMWJlNzgxOWYyLTEwMTI2MjEtMjAyNS0wNi0xNS1lbg==/tiny/F-Hoffmann-La-Roche-Ltd.png?w=150&resize=150,150&ssl=1 "[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients")
Automation Anywhere Reports Strong Q1 Fiscal Year 2026 Growth and Profitability, Driven by Increased Demand for the Agentic Process Automation System
At Imagine 2025, Automation Anywhere Extended its Lead in AI Innovation with…
Wanhua Chemical and ElevenEs signed a strategic agreement for battery materials: Collaborate to create a localized supply chain of battery cathode materials in Europe
MEISHAN, China, June 6, 2025 /PRNewswire/ -- Recently, Wanhua Chemical Battery Technology Co.,…
MemeCore Announces Strategic Entry into South Korea with Acquisition of KOSDAQ-Listed Company
SEOUL, South Korea, June 5, 2025 /PRNewswire/ -- MemeCore, the world's first…
Casio to Release New MT-G Featuring an Original Frame Co-Created by Humans and AI
Newly Developed Structure Fusing Different Materials TOKYO, May 27, 2025 /PRNewswire/ -- Casio…
